http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be2ca48d64ce76bafaf54640cffca7b7
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | London |
| name | Wendy B. London Wendy B London |
| given-name | Wendy B Wendy B. |
| organization-name | Division of Hematology/Oncology, Boston Children’s Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA Department of Pediatrics, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts Wendy B. London, Children's Oncology Group Statistics and Data Center and Dana-Farber Children's Hospital Cancer Center, Boston, MA; Victoria Castel, Unidad de Oncologia Pediatrica Hospital Universitario La Fe, Valencia, Spain; Tom Monclair, Oslo University Hospital, Oslo, Norway; Peter F. Ambros and Ruth L. Ladenstein, Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria; Andrew D.J. Pearson, Institute of Cancer Research and Royal Marsden Hospital, Surrey, United Kingdom;... Douglas R. Strother, University of Calgary and Alberta Children's Hospital, Calgary, Alberta; Paul Thorner, Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada; Wendy B. London, Children's Oncology Group Statistics and Data Center, Children's Hospital Boston and Dana-Farber Cancer Institute, Boston, MA; Mary Lou Schmidt, University of Illinois at Chicago College of Medicine; Susan L. Cohn, University of Chicago, Chicago, IL; Garrett M. Brodeur and John M. Maris, Children's... Division of Pediatric Hematology/Oncology, Harvard Medical School, Dana-Farber/Children's Hospital Cancer and Blood Disorders Center, Boston, MA, USA Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA Dana‐Farber/Boston Children's Cancer and Blood Disorders Center Boston Massachusetts; Department of Pediatrics Harvard Medical School Boston Massachusetts Authors' Affiliations: 1Center for Childhood Cancer, Nationwide Children's Research Institute; 2Nationwide Children's Hospital, Division of Hematology/Oncology/BMT; 3Integrated Biomedical Science Graduate Program, Department of Pediatrics, The Ohio State University, Columbus, Ohio; and 4Children's Oncology Group Statistics and Data Center, University of Florida, Gainesville, Florida Division of Hematology/Oncology and Children's Oncology Group Statistics and Data Center, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA Elizabeth Sokol, MD, Department of Pediatrics and Lurie Children’s Hospital, Northwestern University, Chicago, IL; Ami V. Desai, MD, MSCE, and Mark A. Applebaum, MD, Department of Pediatrics and Comer Children’s Hospital, University of Chicago, Chicago, IL; Dominique Valteau-Couanet, MD, PhD, Institute Gustave Roussy, Villejuif, France; Julie R. Park, MD, Department of Pediatrics, Seattle Children’s Hospital, University of Washington, Seattle, WA; Andrew D.J. Pearson, MD, Paediatric Drug Development,... Boston Children’s Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts Department of Medicine Boston Children's Hospital Boston Massachusetts; Department of Pediatric Oncology Dana‐Farber/Boston Children's Cancer and Blood Disorders Center Boston Massachusetts; Harvard Medical School Boston Massachusetts 3Epidemiology and Health Policy Research, Children's Oncology Group, Gainesville, Florida Arlene Naranjo, University of Florida, Gainesville, FL; Meredith S. Irwin, Hospital for Sick Children, Toronto, ON, Canada; Michael D. Hogarty, University of Pennsylvania, Philadelphia, PA; Susan L. Cohn, The University of Chicago, Chicago, IL; Julie R. Park, University of Washington, Seattle, WA; and Wendy B. London, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA. Department of Pediatric Oncology, Dana‐Farber Cancer Institute Boston Children's Hospital Boston Massachusetts; Division of Hematology/Oncology Boston Children's Hospital Boston Massachusetts From the Dana-Farber Cancer Institute and Children's Hospital Boston, Boston; Children's Oncology Group Statistics and Data Center, Gainesville, FL; Provenance Biopharmaceuticals, Waltham, MA; University of Wisconsin Carbone Cancer Center, Madison WI; Children's Hospital of Los Angeles, Los Angeles; The Scripps Research Institute, La Jolla, CA; University of Texas, Lubbock, TX; University of Chicago, Chicago, IL; National Cancer Institute, Biologic Resources Branch, Frederick, MD; and The Children's... Division of Hematology/Oncology Boston Children's Hospital/Dana‐Farber Cancer Institute Boston Massachusetts Boston Children's Hospital/Dana Farber Cancer Institute Boston Massachusetts From the Children's Cancer Institute Australia for Medical Research, Sydney, Australia; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL; and Department of Statistics, University of Florida, and Children's Oncology Group Statistics Department, Gainesville, FL From the Department of Pediatrics, Northwestern University and Children’s Memorial Hospital, Chicago, IL; Department of Statistics, University of Florida; and Pediatric Oncology Group Statistical Office, Gainesville, FL. Boston Children's Hospital and Dana‐Farber Harvard Cancer Center, Harvard Medical School and Children's Oncology Group Statistics and Data Center Boston Massachusetts Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA From the Children's Oncology Group, Statistics and Data Center, Arcadia, CA; Tampa Children's Hospital, Tampa; Children's Oncology Group, Statistics and Data Center, University of Florida, Gainesville, FL; University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; St Jude Children's Research Hospital, Memphis, TN; University of Rochester Medical Center, Rochester, NY; Children's Hospital, Los Angeles, CA; and Brown Medical School, Providence, RI Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA 02215, USA. Department of Pediatric Oncology Dana‐Farber Cancer Institute Boston Massachusetts Daniel von Allmen, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH; Andrew M. Davidoff, St Jude Children’s Research Hospital, Memphis, TN; Wendy B. London, Boston Children’s Hospital; Wendy B. London and Daphne A. Haas-Kogan, Dana-Farber Cancer Institute; Harvard Medical School; and Daphne A. Haas-Kogan, Brigham and Women’s Hospital, Boston, MA; Collin Van Ryn, University of Florida Health Science Center, Gainesville, FL; Susan G. Kreissman, Duke University School of Medicine, Durham, NC;... Children's Oncology Group, Statistics and Data Center, University of Florida, Gainesville; From the Stanford University Medical Center, Stanford, CA; University of Florida and Children's Oncology Group Statistics and Data Center, Gainesville, FL; Dana-Farber Cancer Center, Boston, MA; Children's Healthcare of Atlanta at Egleston, Atlanta, GA; Indiana University Riley Children's Hospital, Indianapolis, IN; Wayne State University School of Medicine and Children's Hospital of Michigan, Detroit, MI; Children's Hospital Los Angeles, Los Angeles, CA; University of Alabama at Birmingham, AL; and the... Division of Hematology/Oncology, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA; 4Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts. Dana‐Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School Boston Massachusetts USA From the University of Arizona, Department of Pediatrics and Steele Children’s Research Center, Tucson, AZ; Children’s Oncology Group, University of Florida, Gainesville, FL; Northwestern University, Feinberg School of Medicine, Chicago, IL; the Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; the Children’s Hospital of Philadelphia and the University of Pennsylvania, School of Medicine, Philadelphia, PA; A.I. DuPont Hospital for Children, Wilmington, DE; Department of Pathology,... From the Children's Memorial Hospital and the Department of Pediatrics, Northwestern University, Feinberg School of Medicine; Department of Pediatrics, The University of Chicago and Comer Children's Hospital, Chicago, IL; University of Florida, Children's Oncology Group Statistics and Data Center, Gainesville, FL; The Children's Hospital of Philadelphia, Department of Pediatrics, University of Pennsylvania, Philadelphia, PA; Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL;... Authors' Affiliations: Departments of 1Pediatrics, 2Human Oncology, 3Pathology and Laboratory Medicine, and 4Biostatistics and Medical Informatics, and 5School of Pharmacy, Carbone Cancer Center, University of Wisconsin, Madison, Wisconsin; 6The Dana Farber Cancer Institute and Children's Hospital, Boston, Massachusetts; 7Provenance Biopharmaceuticals Corp., Waltham, Massachusetts; 8The Scripps Research Institute, La Jolla, California; 9Children's Oncology Group (COG) Statistics and Data Center, Gainesville, Florida; 10Division of Hematology/Oncology, Children's Hospital of Los Angeles, Los Angeles, California; and 11Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the University of Pennsylvania, Philadelphia, Pennsylvania; Authors' Affiliations: Departments of 1Pediatrics, 2Human Oncology, 3Pathology and Laboratory Medicine, and 4Biostatistics and Medical Informatics, and 5School of Pharmacy, Carbone Cancer Center, University of Wisconsin, Madison, Wisconsin; 6The Dana Farber Cancer Institute and Children's Hospital, Boston, Massachusetts; 7Provenance Biopharmaceuticals Corp., Waltham, Massachusetts; 8The Scripps Research Institute, La Jolla, California; 9Children's Oncology Group (COG) Statistics and Data Center, Gainesville, Florida; 10Division of Hematology/Oncology, Children's Hospital of Los Angeles, Los Angeles, California; and 11Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the University of Pennsylvania, Philadelphia, Pennsylvania 7Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, Massachusetts. 4Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts. Authors' Affiliations: 1Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, Randwick, Sydney, New South Wales, Australia; 2Department of Biology, University of Bologna, Bologna, Italy; 3Children's Hospital, Department of Pediatric Oncology and Hematology, Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany; and 4Children's Oncology Group Statistics and Data Center, Dana-Farber Harvard Cancer Care and Children's Hospital Boston, Massachusetts Kieuhoa T. Vo, Katherine K. Matthay, John Neuhaus, and Steven G. DuBois, Benioff Children's Hospital and University of California, San Francisco, San Francisco; Doug Miniati, Kaiser Permanente Medical Center, Roseville, CA; Wendy B. London, Children's Oncology Group Statistics and Data Center and Dana-Farber Children's Hospital Cancer Center, Boston, MA; Barbara Hero, Children's Hospital, University of Cologne, Köln, Germany; Peter F. Ambros, Children's Cancer Research Institute, St Anne... 5Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School Division of Hematology/Oncology and Children's Oncology Group Statistics and Data Center, Boston, Massachusetts. Wendy Landier, F. Lennie Wong, Jin Lee, Ola Thomas, Heeyoung Kim, and Smita Bhatia, City of Hope, Duarte; Lu Chen, Children's Oncology Group, Monrovia, CA; Kristin Knight, Oregon Health and Science University, Portland, OR; Susan G. Kreissman, Duke University Medical Center, Durham, NC; Mary Lou Schmidt, University of Illinois at Chicago, Chicago, IL; Wendy B. London, Dana-Farber/Harvard Cancer Care, Children's Hospital Boston, Boston, MA; and James G. Gurney, University of Memphis School of Public... 3Children's Oncology Group (COG) Statistics and Data Center, University of Florida, Gainesville, Florida From the Childrens Hospital Los Angeles; University of Southern California Keck School of Medicine, Los Angeles; Children's Oncology Group Operations Center, Arcadia; Children's Hospital Oakland, Oakland, CA; Children's Healthcare of Atlanta, Emory University, Atlanta, GA; Children's Memorial Medical Center at Chicago, Chicago, IL; Texas Children's Cancer Center at Baylor College of Medicine, Houston, TX; The Children's Hospital, Denver, CO; Children's National Medical Center, Washington, DC; Children's... Boston Children's Hospital and Dana‐Farber Harvard Cancer Center Boston Massachusetts; Children Oncology Group Statistics and Data Center Gainesville Florida From Department of Pediatrics and Surgery, Northwestern University and Children’s Memorial Hospital, Chicago, IL; Department of Statistics, University of Florida and Children’s Oncology Group Statistical Department, Gainesville, FL; AstraZeneca Pharmaceuticals LP, Wilmington, DE; Swiss Pediatric Oncology Group, Bern, Switzerland; Baylor College of Medicine, Houston, TX; and AFLAC Cancer Center, Emory University, and Children’s Healthcare of Atlanta, Atlanta, GA. Harvard Medical School, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, Maryland. Julie R. Park, Seattle Children's Hospital and University of Washington, Seattle, WA; Jeffrey R. Scott, Clinton F. Stewart, and Victor M. Santana, St. Jude Children's Research Hospital, Memphis, TN; Wendy B. London, Dana-Farber Children's Cancer Center; Boston, MA; Wendy B. London and Arlene Naranjo, Children's Oncology Group Statistics and Data Center, University of Florida, Gainesville, FL; Peter J. Shaw, The Children's Hospital at Westmead, Sydney, Australia; Susan L. Cohn, University of Chicago,... Authors' Affiliations: 1Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Division of Hematology/Oncology, Children's Hospital Boston, Harvard Medical School; 2Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; 3Department of Pathology, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts; 4Department of Pathology, University of Virginia, Charlottesville, Virginia; 5Department of Pediatric Hematology/Oncology, University Children's Hospital of Bern, Inselspital, Bern, Switzerland; 6Centro Diagnostico Italiano International Center for Oncologic Pathology Consultations, Milan; and 7Department of Pediatrics, Ospedali Riuniti, Bergamo, Italy Department of Pediatric Oncology, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA 8Department of Statistics, University of Florida and Children's Oncology Group Statistical Department, Gainesville, Florida From the Dana–Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School (E.B.E., L.E.L., A.B., C.B., M.F.C., B.M., K.B., S.-Y.P., W.B.L., C.D., M.M.H., D.A.W.), the Harvard Stem Cell Institute, Harvard Medical School (A.B., C.B.), the Gene Therapy Program, Dana–Farber/Boston Children’s Cancer and Blood Disorders Center (A.B., M.F.C., B.M., E.M., A.F., S.-Y.P., C.D., D.A.W.), the Division of Hematology, Brigham and Women’s Hospital, Harvard Medical School (M. Achebe), the Connell... 2Children's Oncology Group Statistics and Data Center, University of Florida, Gainesville, Florida; Boston Children's Hospital/Dana‐Farber Cancer Institute Harvard Medical School Boston Massachusetts Dana‐Farber Boston Children's Cancer and Blood Disorder Center Harvard Medical School Boston Massachusetts From the Comer Children's Hospital and University of Chicago, Chicago, IL; City of Hope, Duarte, CA; Children's Hospital Boston, Harvard Medical School, Boston, MA; and the Children's Oncology Group Statistics and Data Center, University of Florida, Gainesville, FL. Dana‐Farber/Boston Children's Cancer and Blood Disorders Center Harvard Medical School Boston Massachusetts From the Department of Pediatrics, Boston Floating Hospital for Infants and Children, Boston, MA; Department of Hematology/Oncology, Children's Memorial Medical Center at Chicago, Chicago, IL; Department of Radiation Oncology, Midwest Children's Cancer Center, Milwaukee, WI; Department of Pathology, Hospital for Sick Children, Toronto, Ontario, Canada; Department of Pathology and Laboratory Medicine, Hartford Hospital, Hartford, CT; Department of Radiation Oncology, Children's Healthcare of Atlanta at... From the Department of Pediatrics, Northwestern University Medical School; Children’s Memorial Hospital and Robert H. Lurie Comprehensive Cancer Center, Chicago, IL; Department of Statistics, University of Florida, and Pediatric Oncology Group Statistical Office, Gainesville, FL; and Children’s Cancer Institute Australia for Medical Research, University of New South Wales, and Sydney Children’s Hospital, Sydney, Australia. Authors' Affiliations: 1Division of Oncology, the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 2Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 3Children's Oncology Group, Statistics & Data Center, Gainesville, Florida 4Children's Hospital of Boston, and the Dana Farber Harvard Cancer Center, Boston, Massachusetts; Authors' Affiliations: 1Division of Oncology, the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 2Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 3Children's Oncology Group, Statistics & Data Center, Gainesville, Florida 4Children's Hospital of Boston, and the Dana Farber Harvard Cancer Center, Boston, Massachusetts Harvard Medical School, Boston, MA Michael P. La Quaglia, Memorial Sloan Kettering Cancer Center, New York, NY; Daphne Haas-Kogan, Harvard Medical School, Boston, MA; Julie Park, University of Washington, Seattle, WA; Susan G. Kreissman, Duke Medical Center, Durham, NC; Daniel von Allmen, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH; Andrew Davidoff, St Jude Children’s Research Hospital, Memphis, TN; Wendy B. London, Children’s Hospital Boston/Dana-Farber Cancer Institute, Boston, MA; and Geetika Khanna, Mallinckrodt... Authors' Affiliations: 1Graduate Institute of Life Science, National Defense Medical Center, and 2Genomics Research Center, Academia Sinica, Taipei, Taiwan; 3PNN technologies Inc, Woodbridge, Virginia; 4Department of Pediatrics/Hematology-Oncology, University of California San Diego Medical Center, San Diego, California; and 5Children's Oncology Group Statistics and Data Center, University of Florida, Gainesville, Florida 2Dana Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA From the Dana-Farber Cancer Institute, Harvard Medical School; Pediatric Hematology/Oncology, Boston Floating Hospital for Infants & Children, Boston, MA; Children's Oncology Group, University of Florida, Gainesville, FL; Northwestern University, Feinberg School of Medicine, Chicago, IL; Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA; University of Alabama at Birmingham, Birmingham, AL Department of Medicine Boston Children's Hospital Boston Massachusetts Division of Pediatric Hematology-Oncology, Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts. Dana‐Farber/Boston Children's Cancer and Blood Disorders Center Boston Massachusetts From The Children's Hospital of Philadelphia, Philadelphia, PA; Dana-Farber Cancer Institute/Children's Hospital Boston; Boston Floating Hospital, Tufts Medical Center, Boston, MA; Children's Oncology Group Statistics and Data Center, Gainesville, FL; Cincinnati Children's Hospital Medical Center, Cincinnati, OH; St Jude Children's Research Hospital, Memphis, TN; and Comer Children's Hospital, The University of Chicago, Chicago, IL. From the Dana-Farber Cancer Institute/Children's Hospital Boston; Children's Oncology Group Statistics and Data Center, Boston, MA; A.I. DuPont Hospital for Children, Wilmington, DE; Kaiser Permanente Medical Group, Oakland; Children's Hospital Los Angeles, Los Angeles; University of California San Francisco School of Medicine and UCSF Children's Hospital, San Francisco, CA; College of Public Health and Health Professions, University of Florida, Gainesville, FL; University of Chicago, Chicago, IL; and... 8Department of Statistics, University of Florida and Children's Oncology Group Statistics and Data Center Department, Gainesville, Florida Authors' Affiliations: Children's Hospital Los Angeles, Departments of 1Pediatrics and 2Radiology, Keck School of Medicine, University of Southern California, Los Angeles, California; 3Children's Hospital Boston/Dana-Farber Harvard Cancer Care, Boston, Massachusetts; 4Children's Oncology Group Statistics and Data Center; 5University of Florida, Gainesville, Florida; 6Mayo Clinic, Rochester, Minnesota; 7Bern University Children's Hospital, Bern, Switzerland; 8University of Michigan, Ann Arbor, Michigan; 9University of Wisconsin, Madison, Wisconsin; 10Seattle Children's Hospital, Seattle, Washington; 11St. Jude Children's Research Hospital, Memphis, Tennessee; 12University of Chicago, Chicago, Illinois; and 13Cancer Center, Texas Tech University Health Sciences Center, Lubbock, Texas; Authors' Affiliations: Children's Hospital Los Angeles, Departments of 1Pediatrics and 2Radiology, Keck School of Medicine, University of Southern California, Los Angeles, California; 3Children's Hospital Boston/Dana-Farber Harvard Cancer Care, Boston, Massachusetts; 4Children's Oncology Group Statistics and Data Center; 5University of Florida, Gainesville, Florida; 6Mayo Clinic, Rochester, Minnesota; 7Bern University Children's Hospital, Bern, Switzerland; 8University of Michigan, Ann Arbor, Michigan; 9University of Wisconsin, Madison, Wisconsin; 10Seattle Children's Hospital, Seattle, Washington; 11St. Jude Children's Research Hospital, Memphis, Tennessee; 12University of Chicago, Chicago, Illinois; and 13Cancer Center, Texas Tech University Health Sciences Center, Lubbock, Texas Dana‐Farber/Boston Children's Cancer and Blood Disorder Center Boston MA Navin R. Pinto, Mark A. Applebaum, Samuel L. Volchenboum, and Susan L. Cohn, Comer Children's Hospital, University of Chicago, Chicago, IL; Katherine K. Matthay, University of California San Francisco (UCSF) Benioff Children's Hospital, UCSF School of Medicine, San Francisco, CA; Wendy B. London, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA; Peter F. Ambros, Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria; Akira Nakagawara, Saga Medical... Denah R. Taggart, Steven G. DuBois, and Katherine K. Matthay, University of California San Francisco School of Medicine and Benioff Children's Hospital, San Francisco, CA; Wendy B. London, Dana-Farber Cancer Institute/Children's Hospital, Boston, MA; Mary Lou Schmidt, University of Illinois; Susan L. Cohn, University of Chicago, Chicago, IL; Tom F. Monclair, Rikshospitalet University Hospital, Oslo, Norway; Akira Nakagawara, Chiba Cancer Center, Chiba, Japan; Bruno De Bernardi, Istituto Giannina Gaslini,... Authors' Affiliations: 1Center for Medical Genetics; 2Department of Paediatric Hematology and Oncology, Ghent University Hospital, Ghent, Belgium; 3Children's Oncology Group, University of Florida, Gainesville, Florida; 4Department of Cancer Genetics, Royal College of Surgeons in Ireland, and National Children's Research Centre, Dublin, Ireland; 5Pediatric Oncology Unit, Hospital La Fe, Valencia; 6Department of Pathology, Medical School, University of Valencia, Valencia, Spain; 7Applied Biosystems, Foster City, California; 8Department of Pediatric Haematology, Oncology and Endocrinology, Medical University of Gdansk, Gdansk, Poland; 9Department of Pediatric Oncology and Haematology, University Children's Hospital Essen, Essen, Germany; 10Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; 11Children's Oncology Group, Children's Hospital Boston/Dana-Farber Harvard Cancer Center, Boston, Massachusetts; 12Department of Computer Science, Technische Universität Dortmund, Dor Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA;; Dana-Farber Cancer Institute, Boston, MA;; Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA; From the University of California at San Francisco School of Medicine, San Francisco, CA; the Childrens Hospital Los Angeles and the University of Southern California Keck School of Medicine; and the Children's Oncology Group Statistics and Data Center, Los Angeles, CA; the South Carolina Cancer Center, Columbia, SC; and the University of Florida and Children's Oncology Group Statistics and Data Center, Gainesville, FL. Dana‐Farber/Boston Children’s Cancer and Blood Disorders Center Harvard Medical School Boston MA USA Dana‐Farber Children's Hospital Cancer and Blood Disorders Center, Harvard Medical School Boston Massachusetts Dana-Farber Cancer Institute, Boston, MA, USA; Boston Children’s Hospital, Boston, MA, USA Daniel A. Morgenstern and Meredith S. Irwin, Hospital for Sick Children and University of Toronto; Derek Stephens, Hospital for Sick Children, Toronto, ON, Canada; Daniel A. Morgenstern, Great Ormond Street Hospital for Children National Health Service (NHS) Foundation Trust, London; Andrew D.J. Pearson, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom; Wendy B. London, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA; Samuel L. Volchenboum and Susan L.... Department of Pediatric Oncology/Hematology Biostatistics Division Dana‐Farber Cancer Institute, Boston Children's Hospital Boston Massachusetts Dana Farber Cancer Institute and Boston Children's Cancer and Blood Disorders, Boston, MA 1Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts. Children's Oncology Group Statistics and Data Center, Arcadia, CA 91006-3776, USA; Department of Pediatrics, Children's Hospital Boston and Dana-Farber Harvard Cancer Center, Boston, MA 02215-5450, USA Department of Pediatric Oncology Dana‐Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School Boston Massachusetts Shahab Asgharzadeh, Jill A. Salo, Michael Hadjidaniel, Cathy Wei-Yao Liu, Peter Wakamatsu, Judith G. Villablanca, Hiroyuki Shimada, Richard Sposto, and Robert C. Seeger, Children's Hospital Los Angeles and Saban Research Institute; Shahab Asgharzadeh, Lingyun Ji, Judith G. Villablanca, Hiroyuki Shimada, Richard Sposto, and Robert C. Seeger, Keck School of Medicine, University of Southern California, Los Angeles; Katherine K. Matthay, University of California School of Medicine and University of... Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA Division of Hematology/Oncology and Children's Oncology Group Statistics and Data Center Boston Children's Hospital and Dana‐Farber Cancer Institute Harvard Medical School Boston Massachusetts Division of Hematology/Oncology, Boston Children’s Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA 1Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts Children's Oncology Group Statistics and Data Center and Boston Children's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA Division of Pediatric Hematology/Oncology, Children's Hospital Boston, and Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA; Division of Population Sciences, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts Dana-Farber/Boston Children’s Cancer and Blood Disorder Center, Boston, MA; Harvard Medical School Boston Massachusetts; Department of Pediatric Oncology Dana‐Farber Cancer Institute Boston Massachusetts Julie R. Park, Seattle Children’s Hospital and University of Washington School of Medicine, Seattle, WA; Rochelle Bagatell and John M. Maris, Children’s Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA; Susan L. Cohn, University of Chicago, Chicago, IL; Andrew D. Pearson, Institute of Cancer Research and Royal Marsden National Health Service (NHS) Foundation Trust, Sutton, Surrey; Susan Burchill, Leeds Institute of Cancer and Pathology, St James University... |
Incoming Links
Total number of triples: 298.